SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Agouron Pharmaceuticals (AGPH)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
6136 24 0 AGPH
Emcee:  Bhag Karamchandani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
5536 Call agph and ask for Donna Nichols for a start, she vp ir,very cooperative IR John Romeo-10/20/1998
5535 AGPH also is allowed to add 5% to cost of manufacturing viracept,for Roche purcJohn Romeo-10/20/1998
5534 >> oncological colleagues << They probably also once liked BBIOY. scaram(o)uche-10/19/1998
5533 So, lets see, based on "...$2 million for the purchase of 126,758 unregSteve Fancy-10/19/1998
5532 This rumor has been circulating amongst my oncological colleagues. It may be soBradpalm1-10/19/1998
5531 Another version of the IMNR news... Immune Response, Agouron To Work TogetheSteve Fancy-10/19/1998
5530 That would be an interesting development Brad, thanks for the information. Steve Fancy-10/19/1998
5529 I've heard very positive rumors about AGPH's MMP inhibitor AG3340 in eaBradpalm1-10/19/1998
5528 >> Elise apparently went on to say that she is confident they will hit hescaram(o)uche-10/19/1998
5527 Richard, Also, if you explore the web site further, you find that the same cobiodoc-10/19/1998
5526 The comments last week came from Ms Wong. She apparently stated that a compSteve Fancy-10/19/1998
5525 Weekly scrip data for week ending 10/9... New 4088 -1.4% Refills 7510 -3.5%Steve Fancy-10/19/1998
5524 Hey, Clive..... good to hear from you. You're facing Spring while most oscaram(o)uche-10/19/1998
5523 Based on today's activity, looks like options did not play into Friday&#Steve Fancy-10/19/1998
5522 The Immune Response Corporation Receives First $5 million Quarterly Payment froSteve Fancy-10/19/1998
5521 This has all the earmarks of a cancer cure fraud. I would be very careful. Thbiodoc-10/19/1998
5520 A little off subject but I guess relevant to Agouron's cancer pipeline. RiClive Roberts-10/18/1998
5519 Hey all! I'm not even a lurker I just walked in here, but I like Agouron aM. Alexander-10/18/1998
5518 One thing you should be aware of -- in the past (and I'm sure now as well) sam-10/17/1998
5517 Anyone understand what a whisper number that's less than the concensus eSteve Fancy-10/17/1998
5516 add imnr earnings and the potential for more deals coming for agph Sorry Johnord-10/17/1998
5515 Nord ... << add imnr earnings >> I own IMNR. No earnings for a LJohn McCarthy-10/17/1998
5514 Apparently Robertson Stevens suggested that AGPH may miss their numbers Well inord-10/17/1998
5513 >> Maybe its Tiger Management deciding its easier to strangle AGPH again scaram(o)uche-10/16/1998
5512 <From: atp.org.uk Beckerman has “tended to recommend nelfinavir (Viracept) iOliver & Co-10/16/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News